StockNews.com assumed coverage on shares of Otonomy (NASDAQ:OTIC – Get Rating) in a report released on Thursday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Separately, Zacks Investment Research lowered shares of Otonomy from a “buy” rating to a “hold” rating in a report on Friday, March 4th. OTIC opened at $2.30 […]
Otonomy, Inc. (NASDAQ:OTIC – Get Rating) CEO David Allen Weber sold 8,026 shares of the stock in a transaction that occurred on Friday, March 25th. The stock was sold at an average price of $2.39, for a total transaction of $19,182.14. The transaction was disclosed in a document filed with the SEC, which is available […]
Otonomy, Inc. (NASDAQ:OTIC – Get Rating) CEO David Allen Weber sold 11,243 shares of the stock in a transaction on Monday, March 28th. The stock was sold at an average price of $2.41, for a total transaction of $27,095.63. The transaction was disclosed in a document filed with the SEC, which is available at this […]
Analysts expect Otonomy, Inc. (NASDAQ:OTIC – Get Rating) to announce earnings per share (EPS) of ($0.19) for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for Otonomy’s earnings, with estimates ranging from ($0.23) to ($0.17). Otonomy posted earnings of ($0.23) per share in the same quarter last year, which would suggest a […]